IVERIC bio, Inc. Asset Impairment Charges
IVERIC bio, Inc. reported Asset Impairment Charges of $6.90 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2021-03-04
- IVERIC bio, Inc. asset impairment charges for fiscal 2018 was $6.90M.
| Period end | Asset Impairment Charges 12 month |
|---|---|
| 2018-12-31 | $6.90M 10-K · filed 2021-03-04 |